小心类风湿关节炎治疗中的“伏地魔”!结核危(3)
[16] Genovese MC, Schiff M, Luggen M, et al. Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapy[J]. J Rheumatol, 2012 Aug, 39(8):1546-54.
[17] Westhovens R, Kremer JM, Emery P, et al. Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended study[J]. Clin Exp Rheumatol, 2014 Jul-Aug, 32(4):553-62.
[18] Lau CS, Chia F, Dans L, et al. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis[J]. Int J Rheum Dis, 2019 Mar, 22(3):357-375.
[19] Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis[J]. Arthritis Care Res (Hoboken), 2016 Jan, 68(1):1-25.
[20] Moro H, Kikuchi T. Mycobacterium Infections in Rheumatoid Arthritis (Tuberculosis and Nontuberculous Mycobacteriosis) [J ]. Lung Disease Associated with Rheumatoid Arthritis, 2018:16 5-174.
【来源:医学界风湿免疫频道】
版权归原作者所有,向原创致敬
文章来源:《华南国防医学杂志》 网址: http://www.hngfyxzz.cn/zonghexinwen/2020/1110/351.html
上一篇:没有了
下一篇:投档分排名前100高校,深圳大学等17所四非高校,